Corticosteroid Therapy in a Case of Severe Cholestasic Hepatitis Associated with Amoxicillin-Clavulanate

Journal of Medical Toxicology

Volumn 6, Issue 4, 2010, Pages 420-423

  Herrero Herrero, José Ignacio ^a   García Aparicio, Judit ^a  

^a Hospital Los Montalvos   (Spain)

Author keywords

Amoxicillin clavulanate; Drug induced liver injury; Hepatotoxicity

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; PREDNISONE; URSODEOXYCHOLIC ACID;

AGED; ARTICLE; CASE REPORT; CHOLESTATIC HEPATITIS; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ECHOGRAPHY; FEVER; HISTOPATHOLOGY; HUMAN; JAUNDICE; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER INJURY; MALE; PATHOPHYSIOLOGY; PRESCRIPTION; PRURITUS; RESPIRATORY TRACT INFECTION;

AGED; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; CHOLESTASIS, INTRAHEPATIC; DRUG THERAPY, COMBINATION; DRUG-INDUCED LIVER INJURY; GLUCOCORTICOIDS; HUMANS; LIVER FUNCTION TESTS; MALE; PREDNISONE; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 78650044674     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-010-0019-4     Document Type: Article

References (17)

1. Lucena MI, Andrade RJ, Fernández MC, Pachkoria K, Peláez G, Durán JA et al (2006) Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain. Hepatology 44: 850-856.
2. Agencia Española del Medicamento (2006) Uso de la asociación amoxicilina-clavulánico y riesgo de hepatotoxicidad. Boletín de la Tarjeta Amarilla 23: 4. 1.
3. Andrade RJ, Lucena MI, Fernández MC, Peláez G, Pachkoria K, García-Ruiz E, et al (on behalf of the Spanish Group for the Study of Drug-Induced Liver Disease) (2005) Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129: 512-521.
4. Gresser U (2001) Amoxicillin-clavulanic acid therapy may be associated with severe side effects-review of the literature. Eur J Med Res 6: 139-149.
5. Tajiri K, Shimizu Y (2008) Practical guidelines for diagnosis and early management of drug-induced liver injury. World J Gastroenterol 14: 6774-6785.
6. Ferrando J, Sanz P, Sevilla G, Figueras P, Martín I (2002) Insuficiencia hepática secundaria a hepatitis por amoxicilina-ácido clavulánico. Tratamiento con corticoides. Med Interna 19: 551-552.
7. Giannattasio A, D'Ambrosi M, Volpicelli M, Iorio R (2006) Steroid therapy for a case of severe drug-induced cholestasis. Ann Pharmacother 40: 1196-1199.
8. Katsinelos P, Vasiliadis T, Xiarchos P, Patakiouta F, Christodoulou K, Pilpilidis I, Eugenidis N (2000) Ursodeoxycholic acid (UDCA) for the treatment of amoxycillin-clavulanate potassium (Augmentin)-induced intra-hepatic cholestasis: report of two cases. Eur J Gastroenterol Hepatol 12: 365-368.
9. Danan G, Benichou C (1993) Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46: 1323-1330.
10. van den Broek JWG, Buennemeyer BLM, Stricker BHCh (1988) Cholestatische hepatitis door de combinatie amoxicilline en clavulaanzuur (Augmentin). Ned Tijdschr Geneeskd 132: 1495-1497.
11. Hussaini SH, O'Brien CS, Despott EJ, Dalton HR (2007) Antibiotic therapy: a major cause of drug-induced jaundice in southwest England. Eur J Gastroenterol Hepatol 19: 15-20.
12. Larrey D, Vial T, Micaleff A, Babany G, Morichau-Beauchant M, Michel M, Benhamou JP (1992) Hepatitis associated with amoxicillin-clavulanic acid combination: report of 15 cases. Gut 33: 368-371.
13. O'Donohue J, Oien KA, Donaldson P, Underhill J, Clare M, MacSween RN, Mills PR (2000) Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut 47: 717-720.
14. De Abajo FJ, Montero D, Madruga M, García LA (2004) Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol 58: 71-80.
15. Thomson JA, Fairley CK, Ugoni AM, Forbes AB, Purcell PM, Desmond PV et al (1995) Risk factors for the development of amoxcycillin-clavulanic acid associated jaundice. Med J Aust 162: 638-640.
16. Lee W (2003) Drug-induced hepatotoxicity. N Eng J Med 349: 474-485.
17. Luxon BA (2008) Diagnosis and treatment of autoimmune hepatitis. Gastroenterol Clin North Am 37: 461-478.